- Home
- SNDA vs ITOS Comparison
SNDA vs ITOS Comparison
Compare SNDA & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDA
- ITOS
- Stock Information
- Founded
- SNDA 1990
- ITOS 2011
- Country
- SNDA United States
- ITOS United States
- Employees
- SNDA N/A
- ITOS N/A
- Industry
- SNDA Hospital/Nursing Management
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNDA Health Care
- ITOS Health Care
- Exchange
- SNDA Nasdaq
- ITOS Nasdaq
- Market Cap
- SNDA 487.5M
- ITOS 450.9M
- IPO Year
- SNDA 1997
- ITOS 2020
- Fundamental
- Price
- SNDA $25.88
- ITOS $10.15
- Analyst Decision
- SNDA Hold
- ITOS Hold
- Analyst Count
- SNDA 1
- ITOS 6
- Target Price
- SNDA $26.00
- ITOS $10.40
- AVG Volume (30 Days)
- SNDA 15.5K
- ITOS 1.6M
- Earning Date
- SNDA 08-11-2025
- ITOS 08-06-2025
- Dividend Yield
- SNDA N/A
- ITOS N/A
- EPS Growth
- SNDA N/A
- ITOS N/A
- EPS
- SNDA N/A
- ITOS N/A
- Revenue
- SNDA $309,366,000.00
- ITOS N/A
- Revenue This Year
- SNDA $25.57
- ITOS N/A
- Revenue Next Year
- SNDA $6.76
- ITOS N/A
- P/E Ratio
- SNDA N/A
- ITOS N/A
- Revenue Growth
- SNDA 26.39
- ITOS 177.89
- 52 Week Low
- SNDA $19.34
- ITOS $4.80
- 52 Week High
- SNDA $27.85
- ITOS $17.63
- Technical
- Relative Strength Index (RSI)
- SNDA 53.36
- ITOS 1.63
- Support Level
- SNDA $25.57
- ITOS $10.10
- Resistance Level
- SNDA $26.83
- ITOS $10.17
- Average True Range (ATR)
- SNDA 0.56
- ITOS 0.02
- MACD
- SNDA -0.02
- ITOS -0.80
- Stochastic Oscillator
- SNDA 38.70
- ITOS 0.00
About SNDA Sonida Senior Living Inc.
Sonida Senior Living Inc is an owner operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.